TAS::75 0886::TAS MEDICINAL CHEMISTRY FOR NEUROTHERAPEUTICS PROGRAM (MCNP)

Information

• Research Project
• 8356065

• ApplicationId

  8356065

• Core Project Number

  271201100013C-0-0-1

• Full Project Number

  271201100013C-0-0-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  8/17/2011 - 13 years ago

• Project End Date

  -

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2011

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• ALBANY MOLECULAR RESEARCH, INC.

The NIH is developing a Medicinal Chemistry for Neurotherapeutics Program (MCNP) to generate new optimized drugs leads for nervous system disorders. High-throughput screens and basic research studies have led to the discovery of many small molecule compounds with activity in models of nervous system disorders. Some of these compounds have the potential to be transformed into drugs for human use, with chemical modifications to improve their potency and pharmacological properties. The MCNP will support collaborations between a contracted medicinal chemistry facility and researchers (Contributors) with bioactive small molecule compounds and bioactivity assays to develop optimized drug leads.

IC Name

• Activity

  N01

• Administering IC

  NS

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  9951608

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  867

• Ed Inst. Type

• Funding ICs

  NCRR:308048\NEI:3012105\NICHD:358411\NINDS:6273044\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  ALBANY MOLECULAR RESEARCH, INC.

• Organization Department

• Organization DUNS

  787793900

• Organization City

  ALBANY

• Organization State

  NY

• Organization Country

  UNITED STATES

• Organization Zip Code

  122035121

• Organization District

  UNITED STATES